Clinical Trials Show Lucentis Injections Improve Diabetic Macular Edema
Patients with Diabetic Macular Edema, a swelling of the retina that occurs in people who suffer from diabetes retinopathy, have experienced significant and prolonged sight improvement with injections of Roche's Lucentis. In fact, better than 50% of the patients with DME who received monthly injections of Lucentis over 2 years improved so significantly that they would qualify for a driver's license in most states! Currently, Lucentis is indicated for wet age-related macular degeneration.
"This is a real game changer. This can give you a rapid prolonged improvement of vision and it's sustained for at least two years," Dr. David Boyer, who presented the data on Tuesday at the American Diabetes Association (ADA) meeting in San Diego, said in a telephone interview.
